2023 Awardees
Dr. Peter G. Czarnecki, M.D., Beth Israel Deaconess Medical Center
“Ciliary Targeting of Polycystins in the Context of IFT-A Complex Mutations”
Dr. Kai He, Ph.D., Mayo Clinic, Rochester
“Defining Axoneme Polyglutamylation as a Novel Therapeutic Target for ADPKD”
Dr. Katharina Hopp, Ph.D., University of Colorado, Denver Anschutz Medical Campus
“Defining MCJ as a Novel Therapeutic Target for ADPKD”
Dr. Muthusamy Thangaraju, Ph.D., Augusta University
“Netrin-1 is a New and Novel Biomarker and a Potential Therapeutic Target for the ADPKD Cystogenesis”
2022 Awardees
2021 Awardees
